login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Stock News
USA
-
Nasdaq
- NASDAQ:FBIOP -
US34960Q2084
7.7079
USD
+0.01 (+0.1%)
Last: 12/12/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
FBIOP Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
2 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
2 months ago - By: Benzinga
- Mentions:
DH
HCTI
FBIO
LRMR
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
2 months ago - By: Benzinga
- Mentions:
SI
ENTA
DBVT
INTS
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
2 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
2 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
3 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
4 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
7 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
7 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
7 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
9 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
9 months ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech to Participate in October 2024 Investor Conferences
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
a year ago - By: Fortress Biotech, Inc.
- Mentions:
FBIO
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Please enable JavaScript to continue using this application.